FFR-guided PCI and TAVI

DEVICE2 trials

Sponsors

Maatschap Cardiologie Zwolle

Conditions

Aortic StenosisCABGFractional Flow ReserveMulti Vessel Coronary Artery DiseasePCITAVImeervatslijden multivessel disease and aortic valve stenosis

Unknown Phase

TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosis

Active, not recruitingNL-OMON50705

Maatschap Cardiologie Zwollemeervatslijden multivessel disease and aortic valve stenosis

Start: 2018-05-31Target: 170Updated: 2026-06-01

The TransCatheter Valve and Vessels Trial

CompletedNCT03424941

Maatschap Cardiologie ZwolleAortic Stenosis, CABG, Fractional Flow Reserve +3

Start: 2018-05-31End: 2024-06-26Updated: 2025-01-09

Related Papers

TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial.

2024-12-0417 citations

TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale.

2024-02-014 citations

Coronary Microcirculation in Aortic Stenosis: Pathophysiology, Invasive Assessment, and Future Directions.

2020-07-2220 citations